期刊文献+

重庆地区111例自身免疫性肝病流行病学及危险因素分析 被引量:8

Epidemiology and analysis of the risk factors of autoimmune liver disease
在线阅读 下载PDF
导出
摘要 目的:探讨不同类型自身免疫性肝病流行病学特征及相关危险因素。方法:选取2012年8月至2018年8月于重庆医科大学附属第一医院就诊的111例自身免疫性肝病患者为研究对象,按照诊断分为自身免疫性肝炎(autoimmune hepatitis,AIH)、原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)、原发性硬化性胆管炎(primary sclerosing cholangitis,PSC)及重叠综合征(overlapping syndrome,OS),因PSC组患者仅1例,不纳入统计。回顾性分析患者性别、年龄、个人史、伴随疾病和实验室检查资料在各组中的差异。结果:①AIH、PBC、OS组平均发病年龄分别为(53.29±12.43)、(62.91±11.61)、(63.05±11.40)岁,各组间差异具有统计学意义(P<0.01)。家族遗传史在组间差异具有统计学意义(P<0.05)。②实验室指标中,抗线粒体抗体M2型在AIH、PBC、OS各组中阳性率分别为23.2%、52.8%、70.5%,各组间差异具有统计学意义(P<0.01)。AIH及PBC组间天门冬氨酸氨基转移酶(P<0.01)、胆碱酯酶(P<0.05)差异具有统计学意义。天门冬氨酸氨基转移酶(P<0.05)、胆碱酯酶(P<0.05)及碱性磷酸酶(P<0.05)在3组间差异具有统计学意义。③吸烟、性别、饮酒、用药史、临床症状、EB病毒及巨细胞病毒感染、体液免疫在各组间差异无统计学意义(P>0.05)。结论:AIH是自身免疫性肝病的最常见类型。AIH在各类型自身免疫性肝病中起病年龄较小,不同类型自身免疫性肝病有一定遗传倾向。天门冬氨酸氨基转移酶及胆碱酯酶在AIH中升高尤为明显,胆碱酯酶在PBC中升高更为显著。抗线粒体抗体M2型阳性率在重叠综合征中最高。作为自身免疫性肝病的危险因素,吸烟、性别、饮酒、用药史、EB病毒及巨细胞病毒感染对自身免疫性肝病的分组鉴别意义有限。 Objective:To investigate the epidemiologic feature and related risk factors of different type of autoimmune liver diseases(ALD). Methods:A total of 111 patients with ALD from August 2012 to August 2018 in our hospital were selected as study objects and were divided into autoimmune hepatitis(AIH),primary biliary cirrhosis(PBC),primary sclerosing cholangitis(PSC) and AIH-PBC overlapping syndrome(OS)according to the diagnosis. The PSC group had only one patient and was excluded. The differences of gender,age,personal history,documents related with concomitant diseases and laboratory examination in each group were retrospectively analyzed. Results:The average onset age in AIH,PBC,and OS groups was(53.29±12.43)years old,(62.91±11.61)years old and(63.05 ±11.40) years old,respectively;the difference among groups was statistically significant(P <0.01). The genetic family history was statistically significant among groups(P<0.05). The positive rate of anti-mitochondrial antibody M2 in the AIH,the PBC and the OS group were 23.2%,52.8% and 70.5%,respectively,with statistical significance(P<0.01). Aspartate aminotransferase(P<0.01)and cholinesterase(P<0.05)were statistically significant between the AIH group and the PBC group. Aaspartate aminotransferase(P<0.05),cholinesterase(P<0.05)and alkaline phosphatase(P<0.05)among three groups had significant differences. Smoking,drinking,gender,medication history,clinical symptoms,EB virus and cytomegalovirus infection,and humoral immunity were not statistically different among three groups(P>0.05). Conclusion:AIH is the most common type of ALD. AIH has a younger onset in all types of ALD,and different types of ALD have a certain genetic predisposition. Aspartate aminotransferase and cholinesterase are particularly elevated in AIH,and cholinesterase is more prominent in PBC. The positive rate of anti-mitochondrial antibody M2 type is the highest in OS. As for risk factors,smoking,gender,drinking,medication history,EB virus and cytomegalovirus infection have limited significance in the group identification of ALD.
作者 张苑玲 周玉姣 付婧婕 许晓蕾 罗雪 蔡秋红 曾爱中 Zhang Yuanling;Zhou Yujiao;Fu Jingjie;Xu Xiaolei;Luo Xue;Cai Qiuhong;Zeng Aizhong(Department of Infectious Disease,The First Affiliated Hospital of Chongqing Medical University)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2020年第10期1459-1463,共5页 Journal of Chongqing Medical University
关键词 自身免疫性肝病 流行病学 回顾性研究 autoimmune liver diseases epidemiology retrospective study
作者简介 张苑玲,Email:799422743@qq.com,研究方向:自身免疫性肝病;通信作者:曾爱中,Email:aizhong9@sina.com。
  • 相关文献

参考文献8

二级参考文献88

  • 1Agustin Castiella,Eva Zapata,M Isabel Lucena,Raúl J Andrade.drug-induced autoimmune liver disease:a diagnostic dilemma of an increasingly reported disease[J].World Journal of Hepatology,2014,6(4):160-168. 被引量:18
  • 2Giuseppe Maggiore,Silvia Nastasio,Marco Sciveres.Juvenile autoimmune hepatitis: Spectrum of the disease[J].World Journal of Hepatology,2014,6(7):464-476. 被引量:2
  • 3仲人前,耿红莲.自身免疫性疾病实验室诊断进展[J].中华检验医学杂志,2005,28(8):867-869. 被引量:32
  • 4Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31:929-938.
  • 5Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology, 2000,31 : 1005-1013.
  • 6Cohen S,Ohta G, Singer EJ, et al. Immunocytochemical study of gamma globulin in liver in hepatitis and postnecrotic cirrhosis. J Exp Med, 1960,111:285-294.
  • 7Takahashi T,Miura T,Nakamura J,et al. Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology, 2012, 55:846-855.
  • 8Werner M, Wallerstedt S,Lindgren S,et al. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol, 2010, 45:457-467.
  • 9Qixia Wang,Carlo Selmi,Xinmin Zhou,Dekai Qiu,Zenshan Li,Qi Miao,Xiaoyu Chen,Jianhong Wang,Edward L. Krawitt,M. Eric Gershwin,Ying Han,Xiong Ma.Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis[J].Journal of Autoimmunity.2012
  • 10Kirsten Muri Boberg,Roger W. Chapman,Gideon M. Hirschfield,Ansgar W. Lohse,Michael P. Manns,Erik Schrumpf.Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue[J].Journal of Hepatology.2010(2)

共引文献184

同被引文献119

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部